PLAT and ischemic stroke: Currently, the tissue plasminogen activator (tPA) is the only FDA-approved therapy for ischemic stroke (Hughes et al., 2021), and mechanical thrombectomy has the superiority in treating acute ischemic stroke (Flottmann et al., 2018).